Mariola Fotin-Mleczek
Chief Tech/Sci/R&D Officer at CureVac SE
Mariola Fotin-Mleczek active positions
| Companies | Position | Start | End |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Tech/Sci/R&D Officer | 01/01/2013 | - |
Career history of Mariola Fotin-Mleczek
Former positions of Mariola Fotin-Mleczek
| Companies | Position | Start | End |
|---|---|---|---|
| CUREVAC N.V. | Chief Tech/Sci/R&D Officer | 01/10/2018 | 31/01/2022 |
Statistics
International
| Germany | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Private companies | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
